ICO
Closed:

Improving the Precision of Immunotherapies Through Cell Targeting

Improving the Precision of Immunotherapies Through Cell Targeting

Johnson & Johnson Innovation is seeking innovations in cell targeting technology that are highly selective towards immune cells, with a focus on macrophages and fibroblasts, capable of effectively delivering a drug payload to its target on or within the cell of interest. Technologies that enable intracellular delivery are of greatest interest.

Specific Points of Interest

  • Selective targeting of immune cells focusing on macrophages, fibroblasts and also including dendritic cells, myeloid cells, monocytes, T-cells, B-cells, NK cells and neutrophils, including...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology
  • Academic Researcher
  • Centre of Excellence
  • Research Project
  • Spinout Company

Essential Information

Submission Form

Share this call with professional partners.